Marotta Asset Management lessened its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 11.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 65,558 shares of the exchange traded fund’s stock after selling 8,302 shares during the quarter. SPDR S&P Biotech ETF makes up about 1.5% of Marotta Asset Management’s investment portfolio, making the stock its 24th largest holding. Marotta Asset Management owned about 0.10% of SPDR S&P Biotech ETF worth $7,993,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in the business. Capital A Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth $26,000. Davis Capital Management acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at about $35,000. Twin Peaks Wealth Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at about $32,000. Johnson Financial Group Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at about $31,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $40,000.
SPDR S&P Biotech ETF Stock Down 1.7%
XBI opened at $120.31 on Friday. The company’s 50-day moving average price is $125.37 and its 200 day moving average price is $116.13. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $132.09. The firm has a market cap of $8.04 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
